Imugene Limited Expands Shares Quotation on ASX
Company Announcements

Imugene Limited Expands Shares Quotation on ASX

Imugene Limited (AU:IMU) has released an update.

Imugene Limited has announced the application for quotation of new securities on the Australian Securities Exchange (ASX), with a total of 1,060,421 ordinary fully paid shares to be quoted. The issue date for these shares was September 3, 2024, as the company expands its financial footprint. This move could indicate a strategic growth phase for the biotech entity, capturing the interest of investors in the stock market.

For further insights into AU:IMU stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskImugene Limited Begins Innovative Cancer Trial
TipRanks Australian Auto-Generated NewsdeskImugene Launches Phase 1b Trial in Australia
TipRanks Australian Auto-Generated NewsdeskImugene Achieves Milestone in Cancer Treatment Trial
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App